Quantcast

Emergent BioSolutions to manufacture another COVID-19 vaccine candidate

A Gaithersburg life sciences company has signed a $135 million deal with another drug company to provide contract development and manufacturing services for its lead COVID-19 vaccine candidate.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.